EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Demis Pitoni, Arianna Dal Buono iD, Roberto Gabbiadini iD, Vincenzo Ronca iD, Francesca Colapietro iD, Nicola Pugliese iD, Davide Giuseppe Ribaldone iD, Cristina Bezzio iD, Ana Lleo iD, Alessandro Armuzzi iD

Cancers · 27.06.2025 · 17 (13) · 2165

DOI: 10.3390/cancers17132165 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 27.06.2025. Verfasst von Demis Pitoni und 9 weiteren Autor:innen. Beteiligte Einrichtung: IBD Center, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1) Background and Aims: Patients with inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC) face a significantly increased risk of malignancies, including a 10-fold higher risk for colorectal cancer (CRC) and a lifetime risk for cholangiocarcinoma (CCA) exceeding 20%. The mechanisms underlying this elevated risk remain elusive. This review consolidates recent findings on cancer risk in PSC-IBD patients, focusing on molecular pathways, diagnostic innovations, and prevention strategies. (2)

Methods

A comprehensive PubMed search was performed to identify studies published through to March 2025 on oncogenic processes, molecular mechanisms, and advancements in diagnostic and preventive strategies for CRC and CCA in PSC-IBD patients. (3)

Results

Surveillance guidelines recommend an annual colonoscopy for CRC and imaging combined with CA 19-9 monitoring for CCA. Recent studies highlight the role of molecular alterations, including epigenetic modifications, in tumorigenesis. Advances in molecular diagnostics, imaging, and endoscopic technologies are improving the accuracy and timeliness of cancer detection. (4)

Conclusions

PSC-IBD patients remain at high risk for CRC and CCA, emphasizing the need for vigilant surveillance and advanced prevention strategies. Advances in early detection and precision diagnostics offer new opportunities to reduce the cancer burden in this high-risk population.

Schlagwörter

Stichwörter der Autor:innen

colorectal cancerinflammatory bowel diseaseneoplasia riskprimary sclerosing cholangitissurveillance

Autor:innen und Institutionen

  • IBD Center, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
  • Department of Medical Sciences, Division of Gastroenterology, University of Torino, 10126 Torino, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy.
  • Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.

ORCID-Profile: Arianna Dal Buono, Roberto Gabbiadini, Vincenzo Ronca, Francesca Colapietro, Nicola Pugliese, Davide Giuseppe Ribaldone, Cristina Bezzio, Ana Lleo, Alessandro Armuzzi

Zitieren

APA

Pitoni, D., Dal Buono, A., Gabbiadini, R., Ronca, V., Colapietro, F., Pugliese, N., Ribaldone, D. G., Bezzio, C., Lleo, A., & Armuzzi, A. (2025). Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Cancers, 17(13), 2165. https://doi.org/10.3390/cancers17132165

Vancouver

Pitoni D, Dal Buono A, Gabbiadini R, Ronca V, Colapietro F, Pugliese N, et al. Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Cancers. 2025;17(13):2165. doi:10.3390/cancers17132165

BibTeX
@article{Pitoni2025,
  author = {Pitoni, Demis and Dal Buono, Arianna and Gabbiadini, Roberto and Ronca, Vincenzo and Colapietro, Francesca and Pugliese, Nicola and Ribaldone, Davide Giuseppe and Bezzio, Cristina and Lleo, Ana and Armuzzi, Alessandro},
  title = {Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {13},
  pages = {2165},
  doi = {10.3390/cancers17132165}
}
Kostenlos starten →